Literature DB >> 29428497

Pleural effusions in acute decompensated heart failure: Prevalence and prognostic implications.

José Luis Morales-Rull1, Silvia Bielsa2, Alicia Conde-Martel3, Oscar Aramburu-Bodas4, Pau Llàcer5, Miguel Angel Quesada6, Iván Suárez-Pedreira7, Luis Manzano8, Manuel Montero-Pérez Barquero9, José M Porcel10.   

Abstract

BACKGROUND: The incidence of pleural effusions (PEs) in acute decompensated heart failure (ADHF) is not well established. We aimed to determine their prevalence, clinical characteristics and prognostic implications.
METHODS: Retrospective review of 3245 consecutive patients with ADHF from the Spanish RICA Registry. The clinical characteristics of those with or without PEs on chest radiographs were compared and a predictive PE model was generated.
RESULTS: Patient's median age was 80 years and 60% had a left ventricular ejection fraction (LVEF) >50%. PEs were seen in 46% of the cases, and their distribution was as follows: 58% bilateral, 27% right-sided and 14% left-sided. Male gender (OR 2.18; 95%CI 1.23-3.87), serum amino-terminal fraction of the pro-brain natriuretic peptide (NT-pro-BNP) levels >3500 pg/ml (OR 2.2; 95%CI 1.25-3.77), estimated systolic pulmonary artery pressure (sPAP) >55 mm Hg by echocardiography (OR 2.05; 95%CI 1.12-3.75), and serum prealbumin <15 mg/l (OR 1.96; 95%CI 1.08-3.52) were associated with PE development in a multivariate analysis. Serum NT-proBNP >8000 pg/ml, and systolic arterial pressure <110 mm Hg, but not PEs, independently predicted overall 1-year mortality.
CONCLUSIONS: PEs are present on chest radiographs in nearly half of ADHF patients. They are mainly bilateral or right-sided and predominate in males with elevated sPAP on echocardiography and high serum levels of NT-proBNP. PEs do not independently predict 1-year mortality.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heart failure; Natriuretic peptides; Pleural effusion; Pulmonary hypertension

Mesh:

Substances:

Year:  2018        PMID: 29428497     DOI: 10.1016/j.ejim.2018.02.004

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

Review 1.  Interpreting pleural fluid results .

Authors:  Rachel M Mercer; John P Corcoran; Jose M Porcel; Najib M Rahman; Ioannis Psallidas
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

2.  Increased E/A Ratio is a Risk Factor for the Formation of Pleural Effusion in Heart Failure.

Authors:  Chirag Rajyaguru; Amita Kalra; Arang Samim; Belayneh Abejie; Ralph Wessel; Jose Joseph Vempilly
Journal:  Lung       Date:  2019-12-18       Impact factor: 2.584

3.  Cardiopulmonary ultrasound correlates of pleural effusions in patients with congestive heart failure.

Authors:  Hong Li; Jian Chen; Ping-Xiang Hu
Journal:  BMC Cardiovasc Disord       Date:  2022-04-26       Impact factor: 2.174

Review 4.  Diagnostics in Pleural Disease.

Authors:  Anand Sundaralingam; Eihab O Bedawi; Najib M Rahman
Journal:  Diagnostics (Basel)       Date:  2020-12-04

5.  Quantification of pleural effusions on thoracic ultrasound in acute heart failure.

Authors:  Moritz Lindner; Richard Thomas; Brian Claggett; Eldrin F Lewis; John Groarke; Allison A Merz; Montane B Silverman; Varsha Swamy; Jose Rivero; Christian Hohenstein; Scott D Solomon; John Jv McMurray; Michael L Steigner; Elke Platz
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2020-01-24

Review 6.  Biomarkers in the diagnosis of pleural diseases: a 2018 update.

Authors:  José M Porcel
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.